Adverse events · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
24 participants
GRADE not reported
Adverse events · adults with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐specific adverse events · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pneumonia and other serious adverse events · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Adults with COPD
1 finding from 1 review
Adverse eventsd · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse eventsf · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Serious adverse events · people with pulmonary hypertension
Exercise showed no clear difference in serious adverse events compared with control (moderate certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Airway bypass stents showed no clear difference in adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Endobronchial coils leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Endobronchial valves leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Intrabronchial valves leads to higher adverse events at end of compared with control (high certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
Vapour ablation showed no clear difference in adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Adverse events at end of · patients with chronic obstructive pulmonary disease
AeriSeal probably leads to higher adverse events at end of compared with control (moderate certainty).
1 finding from 1 review
Side effects or other adverse events · adults with chronic bronchitis or chronic obstructive pulmonary disease
Summary of findings table ‐ immunostimulant showed no clear difference in adverse events/side effects compared with placebo (high certainty).
1 finding from 1 review
Non‐fatal serious adverse events · patients with chronic obstructive pulmonary disease
Fixed‐dose combination aclidinium/formoterol showed no clear difference in non‐fatal serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Non‐fatal serious adverse events · patients with chronic obstructive pulmonary disease
Umeclidinium bromide showed no clear difference in non‐fatal serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause serious adverse events · chronic obstructive pulmonary disease (COPD). Participants in included studies had an average baseline FEV1 of around 40% predicted and…
Tiotropium leads to lower all‐cause serious adverse events compared with ipratropium (high certainty).
1 finding from 1 review
Non‐fatal serious adverse events · patients with stable chronic obstructive pulmonary disease
It is very uncertain whether aclidinium bromide changes non‐fatal serious adverse events compared with tiotropium (very low certainty).
1 finding from 1 review
Non‐fatal serious adverse events · patients with stable chronic obstructive pulmonary disease
Aclidinium bromide showed no clear difference in non‐fatal serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review